PVLA
Price
$150.13
Change
-$0.26 (-0.17%)
Updated
Sep 11 closing price
Capitalization
2.17B
66 days until earnings call
Intraday BUY SELL Signals
TRVI
Price
$15.90
Change
-$0.01 (-0.06%)
Updated
Sep 11 closing price
Capitalization
2.26B
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PVLA vs TRVI

PVLA vs TRVI Comparison Chart in %
View a ticker or compare two or three
VS
PVLA vs. TRVI commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PVLA is a StrongBuy and TRVI is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRVI($2.26B) and PVLA($2.17B) have the same market capitalization . PVLA YTD gains are higher at: 43.432 vs. TRVI (26.997). TRVI (-52.92M) and PVLA (-54.1M) have comparable annual earnings (EBITDA) . TRVI has more cash in the bank: 319M vs. PVLA (251M). PVLA has less debt than TRVI: PVLA (535K) vs TRVI (605K). PVLA (0) and TRVI (0) have equivalent revenues.
PVLATRVIPVLA / TRVI
Capitalization2.17B2.26B96%
EBITDA-54.1M-52.92M102%
Gain YTD43.43226.997161%
P/E Ratio14.22N/A-
Revenue00-
Total Cash251M319M79%
Total Debt535K605K88%
FUNDAMENTALS RATINGS
PVLA vs TRVI: Fundamental Ratings
PVLA
TRVI
OUTLOOK RATING
1..100
7174
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
1007
SMR RATING
1..100
9895
PRICE GROWTH RATING
1..100
3641
P/E GROWTH RATING
1..100
9100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRVI's Valuation (43) in the Pharmaceuticals Major industry is in the same range as PVLA (74) in the null industry. This means that TRVI’s stock grew similarly to PVLA’s over the last 12 months.

TRVI's Profit vs Risk Rating (7) in the Pharmaceuticals Major industry is significantly better than the same rating for PVLA (100) in the null industry. This means that TRVI’s stock grew significantly faster than PVLA’s over the last 12 months.

TRVI's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as PVLA (98) in the null industry. This means that TRVI’s stock grew similarly to PVLA’s over the last 12 months.

PVLA's Price Growth Rating (36) in the null industry is in the same range as TRVI (41) in the Pharmaceuticals Major industry. This means that PVLA’s stock grew similarly to TRVI’s over the last 12 months.

PVLA's P/E Growth Rating (9) in the null industry is significantly better than the same rating for TRVI (100) in the Pharmaceuticals Major industry. This means that PVLA’s stock grew significantly faster than TRVI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PVLATRVI
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (PVLA: $150.13 vs. TRVI: $15.90)
Brand notoriety: PVLA and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PVLA: 82% vs. TRVI: 120%
Market capitalization -- PVLA: $2.17B vs. TRVI: $2.26B
PVLA [@Biotechnology] is valued at $2.17B. TRVI’s [@Biotechnology] market capitalization is $2.26B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PVLA’s FA Score shows that 1 FA rating(s) are green while TRVI’s FA Score has 1 green FA rating(s).

  • PVLA’s FA Score: 1 green, 4 red.
  • TRVI’s FA Score: 1 green, 4 red.
According to our system of comparison, TRVI is a better buy in the long-term than PVLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PVLA’s TA Score shows that 2 TA indicator(s) are bullish while TRVI’s TA Score has 5 bullish TA indicator(s).

  • PVLA’s TA Score: 2 bullish, 4 bearish.
  • TRVI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TRVI is a better buy in the short-term than PVLA.

Price Growth

PVLA (@Biotechnology) experienced а -4.52% price change this week, while TRVI (@Biotechnology) price change was -7.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

PVLA is expected to report earnings on Nov 17, 2026.

TRVI is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
PVLA
Daily Signal:
Gain/Loss:
TRVI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ASG5.040.04
+0.80%
Liberty All-Star Growth FD
RWR110.040.41
+0.37%
State Street® SPDR® Dow Jones® REIT ETF
PCFI22.47N/A
N/A
POLEN FLOATING RATE INCOME ETF
IBGA23.08-0.01
-0.03%
iShares iBonds Dec 2044 Term Trsy ETF
WTIP37.34-0.27
-0.71%
WisdomTree Inflation Plus Fund

PVLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with VIR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
-0.17%
VIR - PVLA
44%
Loosely correlated
+0.38%
DRMA - PVLA
42%
Loosely correlated
-0.83%
TRVI - PVLA
39%
Loosely correlated
-0.06%
CLDX - PVLA
39%
Loosely correlated
-3.15%
IMMX - PVLA
38%
Loosely correlated
-4.41%
More